Dataset opportunity
Thermographyireland — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Thermographyireland, usable for Diagnostic AI and Computer Vision.
Score
55.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
43%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global AI in medical imaging market = $2.43B in 2026, CAGR 36.91% (2026-2034). Global medical imaging AI training dataset market = $129.0M in 2024, CAGR 24.7% (2024-2030).
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
Medium
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Thermographyireland possesses a valuable Medical Imaging Dataset (modalité Image) derived from its healthcare operations, with medical records serving as proof of origin and context. This dataset is highly suitable for training Diagnostic AI models, as high-quality, diverse medical images are crucial for developing algorithms that can accurately identify patterns and anomalies, thereby enhancing diagnostic precision and efficiency.
Despite the inherent complexities of data sharing due to strict GDPR compliance, mandatory patient consent, and overarching ethical considerations, this data holds significant business value. The global AI in medical imaging market, which relies heavily on such datasets, is projected to grow from USD 2.43 billion in 2026 to USD 29.95 billion by 2034, at a CAGR of 36.91%. Furthermore, the specific market for medical imaging AI training datasets was valued at US$ 129.0 million in 2024, with an estimated CAGR of 24.7% from 2024 to 2030, highlighting the substantial demand and value of this specialized data. ⚠ Diligence (valuable data, access to negotiate): Strict GDPR compliance required for health data.; Patient consent for data sharing is mandatory.; Ethical considerations for medical data. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
- Dataset Specificity66
dominant 'medical_records', sector healthcare, 1 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value64
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
The global AI in medical imaging market, which relies heavily on medical imaging datasets for diagnostic AI, is projected to grow at a Compound Annual Growth Rate (CAGR) of 35.11% from 2026 to 2033, indicating very high buyer demand.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength50
1 evidence types, 5 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation25
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - ICP Audit75
⚠ review — Thermography Clinic Ireland's core business is providing medical thermography scans and interpreting the resulting data to offer health assessments and consultations, which means they are selling intelligence derived from data, making them a bad target for a dormant data marketplace. Issues: The company's core business is selling intelligence/insights (health assessments and consultations based on thermographic data), not just accumulating dormant d; The data (thermograms and their an
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Market read
This opportunity presents access to specialized medical imaging data from Thermographyireland, primarily focused on thermographic scans. This unique dataset is highly valuable for Diagnostic AI development, directly addressing the needs of medical-AI and diagnostic-imaging companies. With the global AI in medical imaging market projected to reach $2.43B by 2026 and a robust CAGR of 36.91%, this data offers a critical resource for advancing non-invasive diagnostic capabilities and capitalizing on significant market growth.
Medical records / imaging
Image · 5 hitsThis category represents medical records primarily comprising thermographic images from breast, oral, head, and neck regions, alongside associated patient data, offering crucial information for AI models focused on non-invasive diagnostics and early detection of various conditions within the rapidly growing medical imaging market.
Deal room
Deal Room — Thermographyireland — Medical Imaging Dataset Opportunity
Medical Imaging Dataset (Image, healthcare). Best AI use-case: Diagnostic AI. Target buyers: Medical-AI & diagnostic-imaging companies. Market: Global AI in medical imaging market = $2.43B in 2026, CAGR 36.91% (2026-2034). Global medical imaging AI training dataset market = $129.0M in 2024, CAGR 24.7% (2024-2030).. Rarity: Medium; accessibility: Restricted. Key risk: Owned by the company — GDPR-sensitive (PII review). Recommended deal structure: Data Sharing Agreement. Investment score 55.9/100.
Buyer persona
Medical-AI & diagnostic-imaging companies
Market
Global AI in medical imaging market = $2.43B in 2026, CAGR 36.91% (2026-2034). Global medical imaging AI training dataset market = $129.0M in 2024, CAGR 24.7% (2024-2030).
Risk
Owned by the company — GDPR-sensitive (PII review)
Action
Data Sharing Agreement
Coverage
Scanned sources
Deliverable
Premium dataset report
Thermographyireland Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in medical imaging market = $2.43B in 2026, CAGR 36.91% (2026-2034). Global medical imaging AI training dataset market = $129.0M in 2024, CAGR 24.7% (2024-2030).. Investment score 55.9/100 (confidence 0.43). Recommended action: Data Sharing Agreement.